Acceptance and potential clinical added value of Sense-IT in psychiatric patients with autism spectrum disorder and/or intellectual disability and/or borderline personality disorder: a proof-of-concept study.

Completed

Conditions: and Intellectual disability
Borderline personality disorder
Autism spectrum disorder
Mental retardation
Autism
10034726

Registration Number: NL-OMON50372

Lead Sponsor: niversiteit Twente

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: Not specified

Target Recruitment: 25

Inclusion Criteria

Patients with ASD and/or ID
In order to be eligible to participate in this study, a subject must meet all
of the following criteria:
1) is admitted to inpatient care at FPA De Boog, GGNet, Warnsveld
2) is diagnosed with ASD and/or ID according to DSM-5 criteria (APA,
2013)
3) is mentally competent and willing to participate in the study

Patients with BPD
In order to be eligible to participate in this study, a subject must meet all
of the following criteria:
1) is admitted to inpatient care at Scelta, GGNet, Apeldoorn
2) is diagnosed with BPD according to DSM-5 criteria (APA, 2013)
3) is mentally competent and willing to participate in the study

Nurses
In order to be eligible to participate in this study, a subject must meet all
of the following criteria:
1) is working at FPA De Boog, GGNet or at Scelta, GGNet

Exclusion Criteria

Patients
A potential subject who meets any of the following criteria will be excluded
from participation in this study:
1) is unable to read, speak or write the Dutch language
2) is using beta-blockers, Nurses
A potential subject who meets any of the following criteria will be excluded
from participation in this study:
1) is unable to read, speak or write the Dutch language.

Study & Design

Study Type: Observational non invasive

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main study parameters include the feasibility and acceptance of Sense-IT as<br /><br>experienced by psychiatric patients with ASD/ID and/or BPD and psychiatric<br /><br>nurses.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary and tertiary parameters include:<br /><br>- The potential (clinical) added value of Sense-IT in a sample of forensic<br /><br>psychiatric patients with ASD/ID/BPD.<br /><br>- The opinions of the participants (patients as well as staff) on the use of<br /><br>Sense-IT and technology in general for improving clinical treatment.</p><br>